Mass Spectrometry Market Report 2026

The mass spectrometry market size has grown rapidly in recent years. It will grow from $7.2 billion in 2025 to $7.93 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to advancement of analytical chemistry techniques, growth of pharmaceutical and biotechnology research, increased regulatory testing requirements, expansion of academic and research laboratories, rising need for precise molecular identification.

The mass spectrometry market size is expected to see rapid growth in the next few years. It will grow to $11.75 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to growing clinical diagnostics applications, expansion of proteomics and metabolomics research, increasing food and environmental safety regulations, rising investments in life science research infrastructure, demand for high-throughput and accurate analytical instruments. Major trends in the forecast period include growing adoption of high-resolution and hybrid mass spectrometry systems, rising demand for mass spectrometry in clinical and diagnostic applications, increasing use of mass spectrometry in environmental and food safety testing, expansion of mass spectrometry in pharmaceutical quality control, rising preference for multi-application and modular mass spectrometry platforms.

The rising prevalence of chronic diseases is anticipated to drive the growth of the mass spectrometry market in the coming years. Chronic diseases are conditions that typically persist for three months or longer and tend to worsen over time. Mass spectrometry techniques are employed to identify, quantify, and analyze biomarkers and metabolites linked to chronic diseases. For example, in April 2025, the Centers for Disease Control and Prevention, a US-based organization dedicated to protecting the nation from health, safety, and security threats through critical scientific research, reported that in 2023, 76.4% (equivalent to 194 million) of US adults had one or more chronic conditions, including 59.5%, 78.4%, and 93% of young, midlife, and older adults, respectively. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the mass spectrometry market.

Key players in the mass spectrometry market are concentrating on developing advanced mass spectrometers, such as the Astral analyzer, to enable novel proteomic discoveries and gain a competitive advantage. The Astral analyzer is a cutting-edge mass spectrometer noted for its rapid throughput, high sensitivity, and extensive proteome coverage. For instance, in June 2023, Thermo Fisher, a US-based supplier of analytical instruments, introduced the Orbitrap Astral mass spectrometer, representing a breakthrough in mass spectrometry technology. The Astral analyzer provides fast throughput, high sensitivity, and broad proteome coverage, allowing researchers to identify previously undetected proteins efficiently. This mass spectrometer supports the discovery of new clinical biomarkers, early disease detection, and the development of treatments for various conditions, including cardiovascular disease and cancer. The technology enhances Thermo Fisher's Orbitrap mass spectrometry platform, delivering up to twice the proteome coverage and up to four times the throughput compared to existing spectrometers.

In June 2025, Bruker Corporation, a U.S.-based technology company, acquired Biocrates Life Sciences AG for an undisclosed amount. Through this acquisition, Bruker Corporation enhances its multiomics strategy by incorporating standardized metabolomics kits, assays, software, and services to reinforce its MS-based metabolomics and integrated multiomics offerings for life-sciences and biopharma clients. Biocrates Life Sciences AG is an Austria-based technology company that focuses on mass-spectrometry-based quantitative metabolite and lipid analysis kits, assays, software, and contract research services, enabling standardized, high-throughput metabolomics.

Major companies operating in the mass spectrometry market are Agilent Technologies Inc., Bruker Corporation, JEOL Ltd., LECO Corporation, PerkinElmer Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, AB Sciex Pte Ltd., Danaher Corporation, Hitachi Ltd., Rigaku Corporation, Advion Inc., AMETEK Inc., Analytik Jena GmbH, DANI Instruments S.p.A., Eurofins Scientific SE, MKS Instruments, Elementar Analysensysteme GmbH, Hiden Analytical Europe GmbH, SPECTRO Analytical Instruments GmbH, EXUM INSTRUMENTS INC., 908 Devices Inc., MassTech Inc., Newomics Inc., Microsaic Systems plc, SCIEX AB, Kore Technologies Ltd., IonSense Inc.

North America was the largest region in the mass spectrometry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the mass spectrometry market size forecast period. The regions covered in the mass spectrometry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mass spectrometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the mass spectrometry market by increasing costs of imported components such as detectors, vacuum systems, and precision electronics. These impacts are most evident in regions reliant on international manufacturing supply chains, including asia-pacific and parts of europe. Higher equipment costs may delay procurement for academic and research institutes. However, tariffs are also encouraging local manufacturing, regional sourcing, and strategic partnerships, supporting long-term market resilience.

The mass spectrometry market research report is one of a series of new reports that provides mass spectrometry market statistics, including mass spectrometry industry global market size, regional shares, competitors with a mass spectrometry market share, detailed mass spectrometry market segments, market trends and opportunities, and any further data you may need to thrive in the mass spectrometry industry. This mass spectrometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Mass spectrometry is an analytical method used to identify and quantify molecules by measuring their mass-to-charge ratio. The process includes ionizing a sample, separating the ions according to their mass-to-charge ratio, and detecting them to produce a mass spectrum.

The primary technologies used in mass spectrometry include hybrid mass spectrometry, single mass spectrometry, and inductively coupled plasma mass spectrometry (ICP-MS). Hybrid mass spectrometry combines multiple mass spectrometry techniques to enhance analytical performance and improve molecular characterization. It is utilized in life science research, drug discovery, environmental testing, food analysis, applied industries, clinical diagnostics, and other areas, and is employed by the pharmaceutical industry, biotechnology sector, research and academic institutions, environmental testing organizations, food and beverage testing companies, petrochemical industry, and others.

The mass spectrometry market consists of revenues earned by entities by providing services such as analytical testing, proteomics analysis, metabolomics studies, drug discovery support, environmental analysis, and forensic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The mass spectrometry market also includes sales of mass spectrometers, ionization sources, and detectors, which are used in providing mass spectrometry services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.